0001437749-23-004161.txt : 20230222
0001437749-23-004161.hdr.sgml : 20230222
20230222163005
ACCESSION NUMBER: 0001437749-23-004161
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230217
FILED AS OF DATE: 20230222
DATE AS OF CHANGE: 20230222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sellers Bakari T.
CENTRAL INDEX KEY: 0001721556
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38299
FILM NUMBER: 23653591
MAIL ADDRESS:
STREET 1: 4231 VOORHEES ROAD
CITY: DENMARK
STATE: SC
ZIP: 29042
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: cbdMD, Inc.
CENTRAL INDEX KEY: 0001644903
STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
IRS NUMBER: 473414576
STATE OF INCORPORATION: NC
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 8845 RED OAK BOULEVARD
CITY: CHARLOTTE
STATE: NC
ZIP: 28217
BUSINESS PHONE: 704-445-3060
MAIL ADDRESS:
STREET 1: 8845 RED OAK BOULEVARD
CITY: CHARLOTTE
STATE: NC
ZIP: 28217
FORMER COMPANY:
FORMER CONFORMED NAME: Level Brands, Inc.
DATE OF NAME CHANGE: 20170202
FORMER COMPANY:
FORMER CONFORMED NAME: LEVEL BEAUTY GROUP, INC.
DATE OF NAME CHANGE: 20150611
4
1
rdgdoc.xml
FORM 4
X0306
4
2023-02-17
0001644903
cbdMD, Inc.
YCBD
0001721556
Sellers Bakari T.
C/O 8845 RED OAK BOULEVARD
CHARLOTTE
NC
28217
1
Common Stock
2023-02-17
4
A
0
5000
0
A
17531
D
Stock Options (Right to Buy)
0.28
2023-02-17
4
A
0
30000
A
2023-02-17
2028-02-17
Common Stock
30000
30000
D
The restricted shares of common stock were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning February 16, 2023. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted shares of common stock vest quarterly in equal increments on June 30, 2023, September 30, 2023, December 31, 2023 and March 31, 2024, subject to continued service as a director of the Issuer on each applicable vesting date.
The stock options were granted under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning February 16, 2023. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The stock options are fully vested.
Not applicable.
/s/ Bakari T. Sellers
2023-02-22